-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Dm9QQ4A8/fBAOM+3BZvEfJKpm/rt14ipRIYS7MoUOAhwCiiTMIvx4takxWIUICUH 3I5hO0he5vgOtk14OjQjjg== 0001104659-07-013439.txt : 20070223 0001104659-07-013439.hdr.sgml : 20070223 20070223150715 ACCESSION NUMBER: 0001104659-07-013439 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070223 DATE AS OF CHANGE: 20070223 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DYAX CORP CENTRAL INDEX KEY: 0000907562 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043053198 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-60267 FILM NUMBER: 07645453 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ BLDG 600 5TH FL CITY: CAMBRIDGE STATE: MA ZIP: 02139 MAIL ADDRESS: STREET 1: ONE KENDALL SQ BLDG 600 STREET 2: 5TH FL CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: BIOTAGE INC DATE OF NAME CHANGE: 19951117 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 SC 13G 1 a07-5164_2sc13g.htm SC 13G

 

 

UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 

SCHEDULE 13G

 

 

Under the Securities Exchange Act of 1934
(Amendment No.     )*

 

Dyax Corp.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

26746E103

(CUSIP Number)

February 20, 2007

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o

Rule 13d-1(b)

x

Rule 13d-1(c)

o

Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 



 

 

CUSIP No. 26746E103

 

 

1.

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
   Genzyme Corporation
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
   06-1047163

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

o

 

 

(b)

o

 

 

Not Applicable

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
The Commonwealth of Massachusetts

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
4,969,820 shares

 

6.

Shared Voting Power
0 shares

 

7.

Sole Dispositive Power
4,969,820 shares

 

8.

Shared Dispositive Power
0 shares

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
4,969,820 shares

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
Not Applicable

 

 

11.

Percent of Class Represented by Amount in Row (9)
11.4%

 

 

12.

Type of Reporting Person (See Instructions)
CO

 

2



 

Item 1.

 

(a)

Name of Issuer
   Dyax Corp.

 

(b)

Address of Issuer’s Principal Executive Offices
   300 Technology Square
   Cambridge, MA 02139

 

Item 2.

 

(a)

Name of Person Filing
   Genzyme Corporation

 

(b)

Address of Principal Business Office or, if none, Residence
   500 Kendall Street
   Cambridge, MA 02142

 

(c)

Citizenship
   Genzyme Corporation is a corporation organized under the laws of The Commonwealth of Massachusetts.

 

(d)

Title of Class of Securities
   Common Stock, par value $0.01 per share

 

(e)

CUSIP Number
   26746E103

 

Item 3.

 

N/A

 

 

 

Item 4.

(a)

Amount beneficially owned:
   4,969,820

 

(b)

Percent of class:
   11.4%

 

(c)

Number of shares as to which the person has:

 

 

(i)

Sole power to vote or to direct the vote:

   4,969,820

 

 

(ii)

Shared power to vote or to direct the vote:

   0 shares

 

 

(iii)

Sole power to dispose or to direct the disposition of:

   4,969,820

 

 

(iv)

Shared power to dispose or to direct the disposition of:

   0 shares

 

3



 

 

Item 5.

Ownership of Five Percent or Less of a Class:
   Not applicable

 

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person:
   Not applicable

 

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:
   Not applicable

 

 

Item 8.

Identification and Classification of Members of the Group:
   Not applicable

 

 

Item 9.

Notice of Dissolution of Group:
   Not applicable

 

 

Item 10.

Certification
   Not applicable

 

 

4



SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 23, 2007

 

 

 

 

GENZYME CORPORATION

 

 

 

 

 

By:

/s/ Michael S. Wyzga

 

Name:

Michael S. Wyzga

 

Title:

Executive Vice President and Chief
Financial Officer

 

5


 -----END PRIVACY-ENHANCED MESSAGE-----